CA2431246A1
(en)
|
2000-12-05 |
2002-06-13 |
Wisconsin Alumni Research Foundation |
Double transposition methods for manipulating nucleic acids
|
US7064246B2
(en)
|
2001-05-01 |
2006-06-20 |
Macrae Amy F |
Use of transposable elements for altering gene expression
|
US7262056B2
(en)
|
2001-11-08 |
2007-08-28 |
Mirus Bio Corporation |
Enhancing intermolecular integration of nucleic acids using integrator complexes
|
EP1458875A2
(de)
|
2001-12-20 |
2004-09-22 |
Sungene GmbH & Co. KGaA |
Verfahren zur transformation von pflanzlichen plastiden
|
WO2004070042A1
(en)
|
2003-02-10 |
2004-08-19 |
Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) |
Transposon-based targeting system
|
WO2004069994A2
(en)
|
2003-02-10 |
2004-08-19 |
Max-Delbrück-Centrum Für Molekulare Medizin (Mdc) |
Transposon-based targeting system
|
GB2403475B
(en)
|
2003-07-01 |
2008-02-06 |
Oxitec Ltd |
Stable integrands
|
US8071364B2
(en)
|
2003-12-24 |
2011-12-06 |
Transgenrx, Inc. |
Gene therapy using transposon-based vectors
|
US20060252140A1
(en)
|
2005-04-29 |
2006-11-09 |
Yant Stephen R |
Development of a transposon system for site-specific DNA integration in mammalian cells
|
US9175295B2
(en)
|
2005-07-05 |
2015-11-03 |
The Chemo-Sero-Therapeutic Research Institute |
Modified transposon vector and its use
|
CA2692501C
(en)
|
2007-07-04 |
2017-10-10 |
Max-Delbrueck-Centrum Fuer Molekulare Medizin |
Hyperactive variants of the transposase protein of the transposon system sleeping beauty
|
US8524979B2
(en)
|
2008-04-14 |
2013-09-03 |
National Taiwan University |
Termination of transgene expression via transposon-mediated break
|
US20110239315A1
(en)
|
2009-01-12 |
2011-09-29 |
Ulla Bonas |
Modular dna-binding domains and methods of use
|
US8399643B2
(en)
|
2009-02-26 |
2013-03-19 |
Transposagen Biopharmaceuticals, Inc. |
Nucleic acids encoding hyperactive PiggyBac transposases
|
EP2441831B9
(en)
|
2009-06-11 |
2019-03-06 |
Inter-University Research Institute Corporation Research Organization of Information and Systems |
Process for production of protein
|
CN110452882A
(zh)
|
2010-12-09 |
2019-11-15 |
宾夕法尼亚大学董事会 |
嵌合抗原受体-修饰的t细胞治疗癌症的用途
|
US20130017978A1
(en)
|
2011-07-11 |
2013-01-17 |
Finnzymes Oy |
Methods and transposon nucleic acids for generating a dna library
|
JP2014533928A
(ja)
|
2011-09-16 |
2014-12-18 |
ザ トラスティーズ オブ ザ ユニバーシティ オブ ペンシルバニア |
癌を処置するためのrna操作t細胞
|
DK3141259T3
(da)
|
2012-03-15 |
2019-09-30 |
Cellectis |
Repeat-variable direster til targeting af nukleotider
|
SI2692865T1
(sl)
|
2012-07-30 |
2015-03-31 |
Nbe-Therapeutics Llc Technology Parc Basel |
S transpozicijo posredovana identifikacija specifičnih vezavnih ali funkcionalnih proteinov
|
ES2717175T3
(es)
|
2013-02-01 |
2019-06-19 |
Selexis Sa |
Expresión mejorada de transgenes y procesamiento
|
JP6463577B2
(ja)
|
2013-05-14 |
2019-02-06 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
改変キメラ抗原受容体(car)t細胞のヒト応用
|
CA2943296C
(en)
|
2014-03-21 |
2022-10-18 |
The Sydney Children's Hospitals Network (Randwick And Westmead) (Incorporating The Royal Alexandra Hospital For Children) |
Stable gene transfer to proliferating cells
|
CN103981204B
(zh)
|
2014-03-24 |
2016-05-04 |
上海海洋大学 |
一种有活性的金鱼Tgf2转座子重组转座酶蛋白的表达方法
|
WO2015157579A2
(en)
|
2014-04-09 |
2015-10-15 |
Dna2.0, Inc. |
Enhanced nucleic acid constructs for eukaryotic gene expression
|
JP2017518082A
(ja)
|
2014-06-17 |
2017-07-06 |
ポセイダ セラピューティクス, インコーポレイテッド |
ゲノム中の特異的遺伝子座にタンパク質を指向させるための方法およびその使用
|
EP3201343B1
(en)
|
2014-09-29 |
2022-03-23 |
The Jackson Laboratory |
High efficiency, high throughput generation of genetically modified mammals by electroporation
|
EP3018200A1
(en)
|
2014-11-07 |
2016-05-11 |
Fondazione Matilde Tettamanti e Menotti de Machi Onlus |
Improved method for the generation of genetically modified cells
|
US20180080051A1
(en)
|
2015-03-31 |
2018-03-22 |
Exeligen Scientific, Inc. |
Cas 9 retroviral integrase and cas 9 recombinase systems for targeted incorporation of a dna sequence into a genome of a cell or organism
|
EP3283635B1
(en)
|
2015-04-13 |
2022-07-06 |
Maxcyte, Inc. |
Methods and compositions for modifying genomic dna
|
WO2016191618A1
(en)
|
2015-05-27 |
2016-12-01 |
Jianbiao Zheng |
Methods of inserting molecular barcodes
|
EP3929286A1
(en)
|
2015-06-17 |
2021-12-29 |
Poseida Therapeutics, Inc. |
Compositions and methods for directing proteins to specific loci in the genome
|
EP3350335B1
(en)
|
2015-09-16 |
2019-11-27 |
T-CURX GmbH |
Improved transposon system for gene delivery
|
CN108601849A
(zh)
|
2015-09-22 |
2018-09-28 |
尤利乌斯·马克西米利安维尔茨堡大学 |
一种在淋巴细胞中高水平的和稳定的基因转移的方法
|
CN105154473B
(zh)
|
2015-09-30 |
2019-03-01 |
上海细胞治疗研究院 |
一种高效安全的转座子整合系统及其用途
|
CN108138171B
(zh)
|
2015-10-08 |
2022-05-13 |
国立大学法人名古屋大学 |
表达嵌合抗原受体的基因修饰t细胞的制备方法
|
KR102249982B1
(ko)
|
2015-12-14 |
2021-05-11 |
게놈프론티어 테라퓨틱스 인코포레이티드 |
트랜스포존 시스템, 이를 포함한 키트, 및 이들의 용도
|
WO2017123758A1
(en)
|
2016-01-12 |
2017-07-20 |
Seqwell, Inc. |
Compositions and methods for sequencing nucleic acids
|
RU2018128464A
(ru)
|
2016-02-25 |
2020-03-25 |
Селл Медика Свитзерленд Аг |
Связывающие элементы против pd-l1
|
EP3420090A1
(en)
|
2016-02-26 |
2019-01-02 |
Poseida Therapeutics, Inc. |
Transposon system and methods of use
|
EP3219800A1
(en)
|
2016-03-15 |
2017-09-20 |
Max-Delbrück-Centrum Für Molekulare Medizin |
A transposon-based transfection system for primary cells
|
WO2017171631A1
(en)
|
2016-03-31 |
2017-10-05 |
Lion Tcr Pte. Ltd. |
Non-activated t cells expressing exogenous virus-specific t cell receptor (tcr)
|
EP3452082A1
(en)
|
2016-05-04 |
2019-03-13 |
Fred Hutchinson Cancer Research Center |
Cell-based neoantigen vaccines and uses thereof
|
CN107523548A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的t细胞及其用途
|
CN107523549A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达激活型抗体的car‑t细胞及其用途
|
CN107523545A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抗体的杀伤性细胞及其用途
|
CN107523547A
(zh)
|
2016-06-20 |
2017-12-29 |
上海细胞治疗研究院 |
一种高效稳定表达抑制性抗体的car‑t细胞及其用途
|
WO2018015936A2
(en)
|
2016-07-21 |
2018-01-25 |
Maxcyte, Inc. |
Methods and compositions for modifying genomic dna
|
JP7201153B2
(ja)
|
2016-08-09 |
2023-01-10 |
プレジデント アンド フェローズ オブ ハーバード カレッジ |
プログラム可能cas9-リコンビナーゼ融合タンパク質およびその使用
|
US11414680B2
(en)
|
2016-08-30 |
2022-08-16 |
Kyushu University National University Corporation |
Method for inserting desired DNA fragment into site located adjacent to binding domain of DNA-binding protein
|
WO2018057779A1
(en)
|
2016-09-23 |
2018-03-29 |
Jianbiao Zheng |
Compositions of synthetic transposons and methods of use thereof
|
IL287286B
(en)
|
2016-09-30 |
2022-09-01 |
Poseida Therapeutics Inc |
Differentiated stem cell memory t cells, methods for their preparation and methods for using them
|
WO2018102612A1
(en)
|
2016-12-02 |
2018-06-07 |
Juno Therapeutics, Inc. |
Engineered b cells and related compositions and methods
|
WO2018112415A1
(en)
|
2016-12-16 |
2018-06-21 |
B-Mogen Biotechnologies, Inc. |
ENHANCED hAT FAMILY TRANSPOSON-MEDIATED GENE TRANSFER AND ASSOCIATED COMPOSITIONS, SYSTEMS, AND METHODS
|
IL310711A
(en)
|
2017-01-10 |
2024-04-01 |
Intrexon Corp |
Modulation of expression of polypeptides through a new system for changing gene expression
|
WO2018140644A1
(en)
|
2017-01-25 |
2018-08-02 |
Musc Foundation For Research Development |
Modified t cells and uses thereof
|